Joint Master Degree in Nanomedicine for Drug Delivery

Language(s) of instruction: English

Length of study: 2 years, full time

Partners: 

Length of Study: 2 years, full time

Course Location:

  • Semester 1: Université de Paris, France or Panepistimio Patron (Patras University), Greece
  • Semester 2: Université de Paris, France + Internship in one of the consortium Universities or at Associated Partner’s labs
  • Semester 3: University degli Studi di Pavia, Italy or Angers University, France
  • Semester 4:  Final Internship in a company or a University Lab

Degrees awarded: Students obtain a degree from each Consortium member (Università degli Studi di Pavia, Angers University, Panepistimio Patron (Patras University) and Université de Paris) + a diploma supplement

Entry Requirements: Bachelor’s degree in Pharmacy, or (under special provisions) in Medicine, Chemistry, Biology, Biotechnology, Chemical Engineering, Biochemistry, Material Sciences or other adequate discipline.

Language pre-requisites: English proficiency is a prerequisite to apply. More info here

Course overview

The Erasmus Mundus Joint Master Degree “Nanomedicine for Drug Delivery” (NANOMED) is a Master program spreading over 23 months. It is aiming at educating young scientists about the general principles of drug development and focuses more specifically on Drug Delivery Systems and Pharmaceutical Technology using both classical dosage forms and innovative delivery systems. It provides essential knowledge to go from basic training in Drug Delivery to advanced knowledge in Nanomedicine.

Joining the NANOMED EMJMD is a great opportunity for future graduates to tackle Nanomedicine through multi-disciplinary perspectives and to learn about the latest advances in the field of Nanotechnology on the development of Advanced Particulate Drug Delivery Systems. The NANOMED Consortium can profit from top-level facilities to deliver cutting-edge course on characterization of nanoparticules, their visualization by microscopy and their biological evaluation both in vitro on cell cultures and in vivo on appropriate animal models.

Skills and competencies developed

Enrolled students are beneficiating from both theoretical and practical courses. Various aspects of pharmaceutical technology related to vectorisation, diagnostic, delivery of innovative drugs (proteins and nucleic acids) but also distinctive features of cosmetic products are part of the curriculum.

  • Skills in the characterization of nanoparticles (diffraction light scattering and electrophoretic mobility, DSC, FTIR, XRD, HPLC and UPLC – UV detection, mass spectroscopy, Raman Spectroscopy, interfacial rheology, etc.)
  • Skills in nanoparticles visualization by microscopy (Confocal Scanning, TEM, AFM, FRAP and SEM Microscopy Units) and their biological evaluation, both in vitro on cell cultures (complement activation, cytotoxicity assay, oral transport model, etc.)
  • Skills in biological evaluation of nanoparticles, both in vitro on cell cultures (complement activation, cytotoxicity assay, oral transport model, etc. and in vivo on appropriate animal models (housing facilities, live animal imaging platforms, etc..).